Q1 2024 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2024-05-14 · accession 0001848809-24-000006
$220.2M
Reported value
21
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 016259202 | — | ALIMERA SCIENCES INC | $53.1M | 24.1% | 13,608,533 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $42.1M | 19.1% | 1,471,904 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $21.4M | 9.72% | 350,666 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $21.0M | 9.55% | 100,000 | PUT | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $19.4M | 8.79% | 6,986,744 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $14.2M | 6.46% | 150,000 | PUT | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $10.1M | 4.58% | 1,528,601 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $7.3M | 3.32% | 319,080 | Common | SOLE |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $6.0M | 2.71% | 500,000 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $4.4M | 1.99% | 3,001,191 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $4.2M | 1.92% | 746,087 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $3.9M | 1.76% | 18,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $2.6M | 1.16% | 600,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.6M | 1.16% | 497,299 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.1M | 0.97% | 904,029 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.6M | 0.75% | 500,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.2M | 0.53% | 650,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.0M | 0.46% | 400,000 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $936,958 | 0.43% | 172,235 | Common | SOLE |
| 49721T309 | EYEGEUR | KIORA PHARMACEUTICALS INC | $776,600 | 0.35% | 1,100,000 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $384,500 | 0.17% | 625,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.